An expert in fluoropolymers shares insights on sourcing appropriate PTFE-based formulations for demanding industrial applications.

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AßOs) for the treatment of Alzheimer ...

This article explores current OSD development and manufacturing trends from a CDMO perspective, including the evolution of outsourcing, emerging technologies, manufacturing advancements and industry ...

CD BioSustainable supports cosmetic R&D and quality management needs by strengthening raw material supply and material basic property analysis capabilities.

An informational 2026 consumer overview of the Lulutox Detox Tea herbal blend - ingredient transparency, weight loss and detox marketing language decoded, updated pricing tiers, return policy ...

The use of acidic MPAs (pH 2–4) is the default in pharmaceutical testing because they suppress silanol ionization (from Si-OH to Si-O -) and improve peak shape for basic drugs. However, highly ...

Pfizer agreement announced in January 2026 for non-exclusive license to utilize Matrix-M® in two infectious disease areas Multiple Material Transfer Agreements signed ...

Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand opening of its new Early Phase Center of Excellence, a state of the art 78,000 square foot facility located in Costa Mesa, ...

NEWARK, DE - February 24, 2026 - PRESSADVANTAGE - AqueLyst has issued a clarification outlining the scientific ...

Aprofood combines specialty medical food ingredients and development services to provide technical support for FSMP ...

The pilot run achieved approximately 99% reaction conversion, 90% isolated yield, and 535 grams of NCT at 99.6% ...

BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...